Article Information
History
- August 18, 2021.
Article Versions
- Version 1 (May 12, 2021 - 14:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pratha Sah1,
- Thomas N. Vilches1,2,
- Affan Shoukat1,
- Meagan C. Fitzpatrick3,1,
- Abhishek Pandey1,
- Burton H. Singer4,
- Seyed M. Moghadas2 and
- Alison P. Galvani1,*
- 1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, USA
- 2Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada
- 3Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA
- 4Emerging Pathogens Institute, University of Florida, P.O. Box 100009, Gainesville, FL 32610, USA
- * Corresponding author; email: alison.galvani{at}yale.edu
Author Contributions: SMM and APG conceptualized with substantial input from PS, TNV, AS, AP, MCF, and BHS. All authors contributed to designing the study. TNV and SMM designed the simulations to conduct the analysis and visualization of the results. PS, SMM wrote the first draft of the paper and all authors meaningfully revised it.